Login Register Cart 0
Generic placeholder image

Current Bioinformatics

Editor-in-Chief

ISSN (Print): 1574-8936
ISSN (Online): 2212-392X

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Systematic Review Article

Genetic Variants of HLA-DRB1 Alleles and the Chance of Developing Rheumatoid Arthritis: Systematic Review and Meta-Analysis

Author(s): Birga A. Mengesha*, Lin Ning and Jian Huang*

Volume 17, Issue 8, 2022

Published on: 05 July, 2022

Page: [674 - 684] Pages: 11

DOI: 10.2174/1574893617666220408085405

Price: $65

conference banner
Abstract

Background: Rheumatoid Arthritis (RA) is more common in those who have specific genetic types of Human Leukocyte Antigen (HLA). One of the most important genetic risk factors for RA lies in the HLA-DRB1 locus.

Objective: This review aimed to determine which HLA-DRB1 alleles were associated with the risk of RA per allele and phenotype group.

Methods: Statistical analyses were performed using RevMan version 5.4.1.

Results: The meta-analysis included nine articles that involved 3004 RA patients and 2384 healthy controls. In the allele group, the frequencies of three HLA-DRB1 alleles, HLA-DRB1*10 (OR = 1.88, 95%CI = 1.25–2.83, p = 0.002), HLA-DRB1*04 (OR = 2.38, 95%CI = 1.73–3.29, p < 0.00001), and HLA-DRB1*01 (OR = 1.32, 95%CI = 1.08–1.61, p = 0.006), were considerably higher in RA patients than in controls, and these alleles potentially increased the chance of disease development. Five HLADRB1 alleles (*03, *07, *11, *13, and *14), were more prevalent in healthy people than in RA patients and may therefore offer protection against disease onset. Only the DRB1*04 subtypes, DRB1*0401 (OR = 1.37, 95 percent CI = 1.05–1.79, p = 0.02) and DRB1*0404 (OR = 1.73, 95% CI = 1.19–12.53, p = 0.004), showed a significant association with the risk of RA in our pooled effect.

Conclusion: Our findings demonstrated a significant relationship between HLA-DRB1 and the risk of RA in various ethnic groups.

Keywords: HLA-DRB1 alleles, rheumatoid arthritis, meta-analysis, RevMan, shared epitope, heterogeneity.

« Previous Next »
Graphical Abstract

[1]
McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med 2011; 365(23): 2205-19.
[http://dx.doi.org/10.1056/NEJMra1004965] [PMID: 22150039]
[2]
Del Puente A, Knowler WC, Pettitt DJ, Bennett PH. High incidence and prevalence of rheumatoid arthritis in Pima Indians. Am J Epidemiol 1989; 129(6): 1170-8.
[http://dx.doi.org/10.1093/oxfordjournals.aje.a115238] [PMID: 2786329]
[3]
Jacobsson LT, Hanson RL, Knowler WC, et al. Decreasing incidence and prevalence of rheumatoid arthritis in Pima Indians over a twenty-five-year period. Arthritis Rheum 1994; 37(8): 1158-65.
[http://dx.doi.org/10.1002/art.1780370808] [PMID: 8053953]
[4]
Alamanos Y, Voulgari PV, Drosos AA. Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: A systematic review. Semin Arthritis Rheum 2006; 36(3): 182-8.
[http://dx.doi.org/10.1016/j.semarthrit.2006.08.006] [PMID: 17045630]
[5]
Uhlig T, Kvien TK, Glennås A, Smedstad LM, Førre O. The incidence and severity of rheumatoid arthritis, results from a county register in Oslo, Norway. J Rheumatol 1998; 25(6): 1078-84.
[PMID: 9632067]
[6]
Helmick CG, Felson DT, Lawrence RC, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum 2008; 58(1): 15-25.
[http://dx.doi.org/10.1002/art.23177] [PMID: 18163481]
[7]
Kaipiainen-Seppanen O, Kautiainen H. Declining trend in the incidence of rheumatoid factor-positive rheumatoid arthritis in Finland 1980-2000. J Rheumatol 2006; 33(11): 2132-8.
[PMID: 17014003]
[8]
Doran MF, Pond GR, Crowson CS, O’Fallon WM, Gabriel SE. Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period. Arthritis Rheum 2002; 46(3): 625-31.
[http://dx.doi.org/10.1002/art.509] [PMID: 11920397]
[9]
Symmons DP, Barrett EM, Bankhead CR, Scott DG, Silman AJ. The incidence of rheumatoid arthritis in the United Kingdom: Results from the Norfolk Arthritis Register. Br J Rheumatol 1994; 33(8): 735-9.
[http://dx.doi.org/10.1093/rheumatology/33.8.735] [PMID: 8055200]
[10]
Kvien TK, Uhlig T, Ødegård S, Heiberg MS. Epidemiological aspects of rheumatoid arthritis: The sex ratio. Ann N Y Acad Sci 2006; 1069(1): 212-22.
[http://dx.doi.org/10.1196/annals.1351.019] [PMID: 16855148]
[11]
Khurana R, Berney SM. Clinical aspects of rheumatoid arthritis. Pathophysiology 2005; 12(3): 153-65.
[http://dx.doi.org/10.1016/j.pathophys.2005.07.009] [PMID: 16125918]
[12]
Doran MF, Crowson CS, Pond GR, O’Fallon WM, Gabriel SE. Predictors of infection in rheumatoid arthritis. Arthritis Rheum 2002; 46(9): 2294-300.
[http://dx.doi.org/10.1002/art.10529] [PMID: 12355476]
[13]
Trowsdale J, Knight JC. Major histocompatibility complex genomics and human disease. Annu Rev Genomics Hum Genet 2013; 14(1): 301-23.
[http://dx.doi.org/10.1146/annurev-genom-091212-153455] [PMID: 23875801]
[14]
Jawaheer D, Li W, Graham RR, et al. Dissecting the genetic complexity of the association between human leukocyte antigens and rheumatoid arthritis. Am J Hum Genet 2002; 71(3): 585-94.
[http://dx.doi.org/10.1086/342407] [PMID: 12181776]
[15]
Scherer HU, Häupl T, Burmester GR. The etiology of rheumatoid arthritis. J Autoimmun 2020; 110102400
[http://dx.doi.org/10.1016/j.jaut.2019.102400] [PMID: 31980337]
[16]
Hill JA, Southwood S, Sette A, Jevnikar AM, Bell DA, Cairns E. Cutting edge: The conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J Immunol 2003; 171(2): 538-41.
[http://dx.doi.org/10.4049/jimmunol.171.2.538] [PMID: 12847215]
[17]
Tobón GJ, Youinou P, Saraux A. The environment, geo-epidemiology, and autoimmune disease: Rheumatoid arthritis. Autoimmun Rev 2010; 9(5): A288-92.
[http://dx.doi.org/10.1016/j.autrev.2009.11.019] [PMID: 19944780]
[18]
Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987; 30(11): 1205-13.
[http://dx.doi.org/10.1002/art.1780301102] [PMID: 2446635]
[19]
Turesson C, Matteson EL. Genetics of rheumatoid arthritis. Mayo Clin Proc 2006; 81(1): 94-101.
[http://dx.doi.org/10.4065/81.1.94] [PMID: 16438485]
[20]
Bax M, van Heemst J, Huizinga TW, Toes RE. Genetics of rheumatoid arthritis: What have we learned? Immunogenetics 2011; 63(8): 459-66.
[http://dx.doi.org/10.1007/s00251-011-0528-6] [PMID: 21556860]
[21]
Holoshitz J. The rheumatoid arthritis HLA-DRB1 shared epitope. Curr Opin Rheumatol 2010; 22(3): 293-8.
[http://dx.doi.org/10.1097/BOR.0b013e328336ba63] [PMID: 20061955]
[22]
Zanelli E, Breedveld FC, de Vries RR. HLA class II association with rheumatoid arthritis: Facts and interpretations. Hum Immunol 2000; 61(12): 1254-61.
[http://dx.doi.org/10.1016/S0198-8859(00)00185-3] [PMID: 11163080]
[23]
Prahalad S, Thompson SD, Conneely KN, et al. Hierarchy of risk of childhood-onset rheumatoid arthritis conferred by HLA-DRB1 alleles encoding the shared epitope. Arthritis Rheum 2012; 64(3): 925-30.
[http://dx.doi.org/10.1002/art.33376] [PMID: 21953520]
[24]
Gregersen PK. Teasing apart the complex genetics of human autoimmunity: Lessons from rheumatoid arthritis. Clin Immunol 2003; 107(1): 1-9.
[http://dx.doi.org/10.1016/S1521-6616(02)00045-1] [PMID: 12738244]
[25]
Bridges SL Jr, Kelley JM, Hughes LB. The HLA-DRB1 shared epitope in Caucasians with rheumatoid arthritis: A lesson learned from tic-tac-toe. Arthritis Rheum 2008; 58(5): 1211-5.
[http://dx.doi.org/10.1002/art.23433] [PMID: 18438835]
[26]
Yuan G, Shi G, Li Z. Molecular analysis of HLA-DR beta polymorphism in Han nationality patients with rheumatoid arthritis Zhonghua Yi Xue Za Zhi 1998; 78(3): 172-4.
[PMID: 10923522]
[27]
Ruiz-Morales JA, Vargas-Alarcón G, Flores-Villanueva PO, et al. HLA-DRB1 alleles encoding the “shared epitope” are associated with susceptibility to developing rheumatoid arthritis whereas HLA-DRB1 alleles encoding an aspartic acid at position 70 of the beta-chain are protective in Mexican Mestizos. Hum Immunol 2004; 65(3): 262-9.
[http://dx.doi.org/10.1016/j.humimm.2003.12.009] [PMID: 15041166]
[28]
Ioannidis JP, Tarassi K, Papadopoulos IA, et al. Shared epitopes and rheumatoid arthritis: Disease associations in greece and meta-analysis of mediterranean european populations. Semin Arthritis Rheumat 2002; pp. 361-70.
[http://dx.doi.org/10.1053/sarh.2002.31725]
[29]
Gorman JD, Criswell LA. The shared epitope and severity of rheumatoid arthritis. Rheum Dis Clin North Am 2002; 28(1): 59-78.
[http://dx.doi.org/10.1016/S0889-857X(03)00069-3] [PMID: 11840698]
[30]
Jun KR, Choi SE, Cha CH, et al. Meta-analysis of the association between HLA-DRB1 allele and rheumatoid arthritis susceptibility in Asian populations. J Korean Med Sci 2007; 22(6): 973-80.
[http://dx.doi.org/10.3346/jkms.2007.22.6.973] [PMID: 18162709]
[31]
Delgado-Vega AM, Anaya JM. Meta-analysis of HLA-DRB1 polymorphism in Latin American patients with rheumatoid arthritis. Autoimmun Rev 2007; 6(6): 402-8.
[http://dx.doi.org/10.1016/j.autrev.2006.11.004] [PMID: 17537386]
[32]
Gorman JD, David-Vaudey E, Pai M, Lum RF, Criswell LA. Lack of association of the HLA-DRB1 shared epitope with rheumatoid nodules: An individual patient data meta-analysis of 3,272 Caucasian patients with rheumatoid arthritis. Arthritis Rheum 2004; 50(3): 753-62.
[http://dx.doi.org/10.1002/art.20119] [PMID: 15022316]
[33]
Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31(3): 315-24.
[http://dx.doi.org/10.1002/art.1780310302] [PMID: 3358796]
[34]
Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: An American College of rheumatology/european league against rheumatism collaborative initiative. Arthritis Rheum 2010; 62(9): 2569-81.
[http://dx.doi.org/10.1002/art.27584] [PMID: 20872595]
[35]
Wells GA, Shea B, O’Connell D, et al. The newcastle-ottawa scale (nos) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa, Canada: University of Ottawa 2000.
[36]
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315(7109): 629-34.
[http://dx.doi.org/10.1136/bmj.315.7109.629] [PMID: 9310563]
[37]
Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000; 56(2): 455-63.
[http://dx.doi.org/10.1111/j.0006-341X.2000.00455.x] [PMID: 10877304]
[38]
Flanders WD. A new variance estimator for the mantel-haenszel odds ratio. Biometrics 1985; 41(3): 637-42.
[http://dx.doi.org/10.2307/2531283]
[39]
Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21(11): 1539-58.
[http://dx.doi.org/10.1002/sim.1186] [PMID: 12111919]
[40]
Chen Z, Zhang G, Li J. Goodness-of-fit test for meta-analysis. Sci Rep 2015; 5(1): 16983.
[http://dx.doi.org/10.1038/srep16983] [PMID: 26592212]
[41]
Payami H, Joe S, Farid NR, et al. Relative predispositional effects (RPEs) of marker alleles with disease: HLA-DR alleles and Graves disease. Am J Hum Genet 1989; 45(4): 541-6.
[PMID: 2491013]
[42]
Citera G, Pra FD, Waimann CA, et al. Frequency of human leukocyte antigens class II-DR alleles (HLA-DRB1) in Argentinian patients with early arthritis. Clin Rheumatol 2019; 38(3): 675-81.
[http://dx.doi.org/10.1007/s10067-018-4319-4] [PMID: 30306282]
[43]
Said NM, Ezzeldin N, Said D, Ebaid AM, Atef DM, Atef RM. HLA-DRB1, IRF5, and CD28 gene polymorphisms in Egyptian patients with rheumatoid arthritis: Susceptibility and disease activity. Genes Immun 2021; 22(2): 93-100.
[http://dx.doi.org/10.1038/s41435-021-00134-8] [PMID: 34017081]
[44]
Vetchinkina EA, Mikhaylenko DS. Genetic factors of predisposition and clinical characteristics of rheumatoid arthritis in Russian patients. J Pers Med 2021; 11(6): 469.
[http://dx.doi.org/10.3390/jpm11060469]
[45]
Govind N, Reynolds RJ. Hla-drb1 amino acid positions and residues associated with antibody-positive rheumatoid arthritis in black South Africans. 2019; 46: 138-44.
[46]
Oka S, Furukawa H, Kawasaki A, et al. Protective effect of the HLA-DRB1*13:02 allele in Japanese rheumatoid arthritis patients. PLoS One 2014; 9(6)e99453
[http://dx.doi.org/10.1371/journal.pone.0099453] [PMID: 24911054]
[47]
Nakagawa S, Noble DW, Senior AM, Lagisz M. Meta-evaluation of meta-analysis: Ten appraisal questions for biologists. BMC Biol 2017; 15(1): 18.
[http://dx.doi.org/10.1186/s12915-017-0357-7] [PMID: 28257642]
[48]
Lee YH. An overview of meta-analysis for clinicians. Korean J Intern Med (Korean Assoc Intern Med) 2018; 33(2): 277-83.
[http://dx.doi.org/10.3904/kjim.2016.195] [PMID: 29277096]
[49]
Yelamos J, Garcia-Lozano JR, Moreno I, et al. Association of HLA-DR4-Dw15 (DRB1*0405) and DR10 with rheumatoid arthritis in a Spanish population. Arthritis Rheum 1993; 36(6): 811-4.
[http://dx.doi.org/10.1002/art.1780360611] [PMID: 8507223]
[50]
Ollier W, Thomson W. Population genetics of rheumatoid arthritis. Rheum Dis Clin North Am 1992; 18(4): 741-59.
[http://dx.doi.org/10.1016/S0889-857X(21)00149-6] [PMID: 1280845]
[51]
Liu Q, Teng Y. Relation between shared epitope of hla-dr antigen b chain and rheumatoid arthritis. Chinese J Rheumatol 2000; 4: 153-5.
[52]
Castro F, Acevedo E, Ciusani E, Angulo JA, Wollheim FA, Sandberg-Wollheim M. Tumour necrosis factor microsatellites and HLA-DRB1*, HLA-DQA1*, and HLA-DQB1* alleles in Peruvian patients with rheumatoid arthritis. Ann Rheum Dis 2001; 60(8): 791-5.
[http://dx.doi.org/10.1136/ard.60.8.791] [PMID: 11454644]
[53]
Willkens RF, Nepom GT, Marks CR, Nettles JW, Nepom BS. Association of HLA-Dw16 with rheumatoid arthritis in Yakima Indians. Further evidence for the “shared epitope” hypothesis. Arthritis Rheum 1991; 34(1): 43-7.
[http://dx.doi.org/10.1002/art.1780340107] [PMID: 1701997]
[54]
Kong KF, Yeap SS, Chow SK, Phipps ME. HLA-DRB1 genes and susceptibility to rheumatoid arthritis in three ethnic groups from Malaysia. Autoimmunity 2002; 35(4): 235-9.
[http://dx.doi.org/10.1080/08916930290024179] [PMID: 12482190]
[55]
Benazet JF, Reviron D, Mercier P, Roux H, Roudier J. HLA-DRB1 alleles associated with rheumatoid arthritis in southern France. Absence of extraarticular disease despite expression of the shared epitope. J Rheumatol 1995; 22(4): 607-10.
[PMID: 7540691]
[56]
Bettencourt A, Carvalho C, Leal B, et al. The protective role of hla-drb1*13 in autoimmune diseases. J Immunol Res 2015; 2015948723
[http://dx.doi.org/10.1155/2015/948723] [PMID: 26605347]
[57]
Hajeer AH, Dababneh A, Makki RF, et al. Different gene loci within the HLA-DR and TNF regions are independently associated with susceptibility and severity in Spanish rheumatoid arthritis patients. Tissue Antigens 2000; 55(4): 319-25.
[http://dx.doi.org/10.1034/j.1399-0039.2000.550405.x] [PMID: 10852383]
[58]
Gonzalez-Gay MA, Garcia-Porrua C, Hajeer AH. Influence of human leukocyte antigen-DRB1 on the susceptibility and severity of rheumatoid arthritis. Semin Arthritis Rheum 2002; 31(6): 355-60.
[http://dx.doi.org/10.1053/sarh.2002.32552] [PMID: 12077707]
[59]
Louzada-Júnior P, Freitas MV, Oliveira RD, et al. A majority of Brazilian patients with rheumatoid arthritis HLA-DRB1 alleles carry both the HLA-DRB1 shared epitope and anti-citrunillated peptide antibodies. Braz J Med Biol Res 2008; 41(6): 493-9.
[http://dx.doi.org/10.1590/S0100-879X2008005000021] [PMID: 18560674]
[60]
van der Helm-van Mil AH, Huizinga TW, Schreuder GM, Breedveld FC, de Vries RR, Toes RE. An independent role of protective HLA class II alleles in rheumatoid arthritis severity and susceptibility. Arthritis Rheum 2005; 52(9): 2637-44.
[http://dx.doi.org/10.1002/art.21272] [PMID: 16142711]
[61]
Carrier N, Cossette P, Daniel C, et al. The DERAA HLA-DR alleles in patients with early polyarthritis: Protection against severe disease and lack of association with rheumatoid arthritis autoantibodies. Arthritis Rheum 2009; 60(3): 698-707.
[http://dx.doi.org/10.1002/art.24353] [PMID: 19248090]
[62]
Liu SC, Chang TY, Lee YJ, et al. Influence of HLA-DRB1 genes and the shared epitope on genetic susceptibility to rheumatoid arthritis in Taiwanese. J Rheumatol 2007; 34(4): 674-80.
[PMID: 17309132]
[63]
Uçar F, Karkucak M. Alemdaroğlu E, et al. HLA-DRB1 allele distribution and its relation to rheumatoid arthritis in eastern Black Sea Turkish population. Rheumatol Int 2012; 32(4): 1003-7.
[http://dx.doi.org/10.1007/s00296-010-1792-8] [PMID: 21246357]
[64]
Wang J, Zhang H, Wang GQ, Quan Y. HLA-DRB1 gene polymorphisms and its associations with rheumatoid arthritis in Chinese Han women of Shaanxi province, northwest of China. Int J Immunogenet 2016; 43(1): 25-31.
[http://dx.doi.org/10.1111/iji.12242] [PMID: 26615796]
[65]
Sandoughi M, Fazaeli A, Bardestani G, Hashemi M. Frequency of HLA-DRB1 alleles in rheumatoid arthritis patients in Zahedan, southeast Iran. Ann Saudi Med 2011; 31(2): 171-3.
[http://dx.doi.org/10.4103/0256-4947.78205] [PMID: 21422655]
[66]
Muazzam AG, Mansoor A, Ali L, et al. Association of HLA-DRB1 and -DQB1alleles and haplotypes with rheumatoid arthritis in a Pakistani population. Arthritis Res Ther 2013; 15(4): R95.
[http://dx.doi.org/10.1186/ar4275] [PMID: 23968403]
[67]
Mourad J, Monem F. HLA-DRB1 allele association with rheumatoid arthritis susceptibility and severity in Syria. Rev Bras Reumatol 2013; 53(1): 47-56.
[PMID: 23588515]
[68]
Ben Hamad M, Mahfoudh N, Marzouk S, et al. Association study of human leukocyte antigen-DRB1 alleles with rheumatoid arthritis in south Tunisian patients. Clin Rheumatol 2012; 31(6): 937-42.
[http://dx.doi.org/10.1007/s10067-012-1954-z] [PMID: 22349877]
[69]
Usnayo MJ, Andrade LE, Alarcon RT, et al. Study of the frequency of HLA-DRB1 alleles in Brazilian patients with rheumatoid arthritis. Rev Bras Reumatol 2011; 51(5): 474-83.
[http://dx.doi.org/10.1590/S0482-50042011000500007] [PMID: 21952999]

Rights & Permissions Print Cite
Article Metrics
3
© 2024 Bentham Science Publishers | Privacy Policy